Your browser doesn't support javascript.
loading
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
Zapata, Brianne; Alvarez, Danya N; Farah, Sabrina; Garcia-de-la-Maria, Cristina; Miro, Jose M; Sakoulas, George; Bayer, Arnold S; Mishra, Nagendra N.
Afiliação
  • Zapata B; Divison of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Alvarez DN; Divison of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Farah S; Center for Infectious Diseases, California State Department of Public Health, Richmond, CA, USA.
  • Garcia-de-la-Maria C; Divison of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Miro JM; Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Sakoulas G; Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Bayer AS; Division of Host-Microbe Systems & Therapeutics, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Mishra NN; Divison of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
Curr Microbiol ; 75(8): 1062-1067, 2018 Aug.
Article em En | MEDLINE | ID: mdl-29651552

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Daptomicina / Streptococcus oralis / Streptococcus mitis / Antibacterianos Limite: Humans Idioma: En Revista: Curr Microbiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Daptomicina / Streptococcus oralis / Streptococcus mitis / Antibacterianos Limite: Humans Idioma: En Revista: Curr Microbiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos